OPEC: the company has obtained the preparation license for medical institutions, but has not yet launched sales of atropine

China’s E-bike Brands Going Global: A Review of 26 Leading Players

With the global e-bike market continuing to expand, Chinese e-bike companies are gradually shifting from being a manufacturing powerhouse to becoming a meaningful force in global competition. This article reviews a group of Chinese e-bike players and examines their overseas positioning and market entry paths—looking at how Chinese brands are securing a foothold in the next wave of globalization.

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Precision Reducer Manufacturer Talls Intelligent Technology Secures CNY 140 Million in Financing

Talls Intelligent Technology（陶世智能）Raises CNY 140 Million, Secures Order for 100,000 Dexterous Hands

SEEV Raises Nearly CNY 200 Million in Two Funding Rounds, Targeting Mass-Production Window for Full-Color AR Waveguides

EO reported on August 5 that AR diffractive waveguide manufacturer SEEV（广纳四维）had completed two consecutive funding rounds, raising nearly CNY 200 million in total.

Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion

Alphamab Oncology (康宁杰瑞生物制药) has licensed the overseas rights to its experimental cancer drug JSKN016 to US-based Pathos AI in a deal potentially worth more than US$2.2 billion, marking another major overseas licensing agreement for China’s rapidly expanding innovative-drug sector.